59: Neutrocheck, an at-home test for neutropenic sepsis with Umaima Ahmad from 52North
15 Minutes With The Doctor: Learn from Healthcare Entrepreneurs and Innovators
English - January 25, 2024 18:32 - 20 minutes - 28.7 MB - ★★★★★ - 3 ratingsScience Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
On this episode, Vinay is joined by co-founder Umaima Ahmad, to discuss their startup 52North and their ambitious tech that powers a life-saving product. Neutrocheck is device for those undergoing chemotherapy and who are at risk of neutropenic sepsis. With a background in financial law, Umaima and her team of co-founders were inspired to solve a problem that is a serious side-effect for those needing crucial treatment for cancer. Hear all about their journey to creating the product and how it all took off after a small grant of only ten thousand pounds.
Discover:
How Umaima’s mid-career Masters led to the development of 52North
How her background as a financial lawyer gave her the transferable skills to become an entrepreneur
How a Cambridge University mentorship programme offered them their first investment
How they developed a product to diagnose neutropenic sepsis, a common side effect of chemotherapy without unnecessary A&E visits
How Neutrocheck, their product and app, can save time, money, and lives in cancer care
How using COVID-19 lateral flow kits as a stimulus helped them brainstorm a solution for diagnosing Neutropenic Sepsis
How branching out into digital and AI is being tempered by targets for accessibility and health equity
How patient feedback and input from medical professionals has been essential in building the solution
How they became the first product to be fully endorsed by the MacMillan Cancer Trust in 100 years
How Neutrocheck could reduce costs to the NHS by around £70 million
How they are beginning to explore new avenues for detecting disease using their portable low-cost device
Guest: Umaima Ahmad
Website: https://52north.health/
Host: Dr Vinay Shankar
Website: https://www.oncedaily.co
Podcast: 15 Minutes With The Doctor
On this episode, Vinay is joined by co-founder Umaima Ahmad, to discuss their startup 52North and their ambitious tech that powers a life-saving product. Neutrocheck is device for those undergoing chemotherapy and who are at risk of neutropenic sepsis. With a background in financial law, Umaima and her team of co-founders were inspired to solve a problem that is a serious side-effect for those needing crucial treatment for cancer. Hear all about their journey to creating the product and how it all took off after a small grant of only ten thousand pounds.
Discover:
How Umaima’s mid-career Masters led to the development of 52North
How her background as a financial lawyer gave her the transferable skills to become an entrepreneur
How a Cambridge University mentorship programme offered them their first investment
How they developed a product to diagnose neutropenic sepsis, a common side effect of chemotherapy without unnecessary A&E visits
How Neutrocheck, their product and app, can save time, money, and lives in cancer care
How using COVID-19 lateral flow kits as a stimulus helped them brainstorm a solution for diagnosing Neutropenic Sepsis
How branching out into digital and AI is being tempered by targets for accessibility and health equity
How patient feedback and input from medical professionals has been essential in building the solution
How they became the first product to be fully endorsed by the MacMillan Cancer Trust in 100 years
How Neutrocheck could reduce costs to the NHS by around £70 million
How they are beginning to explore new avenues for detecting disease using their portable low-cost device
Guest: Umaima Ahmad
Website: https://52north.health/
Host: Dr Vinay Shankar
Website: https://www.oncedaily.co
Podcast: 15 Minutes With The Doctor